Delve Insight Market Research Reports

Title published price

Afinitor (everolimus) - Drug Insight and Market Forecast - 2030

By Delve Insight

Overview "Afinitor (everolimus) - Drug Insight and Market Forecast - 2030" report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Afinitor ( ...

20-Feb-2020 $2750

Alphanate - Drug Insight and Market Forecast - 2030

By Delve Insight

Overview "Alphanate - Drug Insight and Market Forecast - 2030" report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Alphanate in Seven Maj ...

20-Feb-2020 $2750

Benlysta (belimumab) - Drug Insight and Market Forecast - 2030

By Delve Insight

Overview "Benlysta (belimumab) - Drug Insight and Market Forecast - 2030" report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Benlysta (b ...

20-Feb-2020 $2750

Doptelet (avatrombopag) - Drug Insight and Market Forecast - 2030

By Delve Insight

Overview "Doptelet (avatrombopag) - Drug Insight and Market Forecast - 2030" report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Doptelet ...

20-Feb-2020 $2750

Epidiolex (cannabidiol) - Drug Insight and Market Forecast - 2030

By Delve Insight

Overview "Epidiolex (cannabidiol) - Drug Insight and Market Forecast - 2030" report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Epidiole ...

20-Feb-2020 $2750

Esbriet (pirfenidone) - Drug Insight and Market Forecast - 2030

By Delve Insight

Overview "Esbriet (pirfenidone) - Drug Insight and Market Forecast - 2030" report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Esbriet (p ...

20-Feb-2020 $2750

Firdapse (amifampridine) - Drug Insight and Market Forecast - 2030

By Delve Insight

Overview "Firdapse (amifampridine) - Drug Insight and Market Forecast - 2030" report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Firdaps ...

20-Feb-2020 $2750

Hemlibra (emicizumab-kxwh) - Drug Insight and Market Forecast - 2030

By Delve Insight

Overview "Hemlibra - Drug Insight and Market Forecast—2030" report by DelveInsight outlays comprehensive insights of the product based on routine prophylaxis to prevent or reduce the frequency of bleeding ...

20-Feb-2020 $2750

Ibrance (palbociclib) - Drug Insight and Market Forecast - 2030

By Delve Insight

Overview "Ibrance- Drug Insight and Market Forecast — 2030" report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of Hormone Receptor positive (HR+), Human Epidermal Growth Factor Receptor 2 n ...

20-Feb-2020 $2750

Imbruvica (ibrutinib) - Drug Insight and Market Forecast - 2030

By Delve Insight

Overview "Imbruvica (ibrutinib) - Drug Insight and Market Forecast - 2030" report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Imbruvica ...

20-Feb-2020 $2750

Kisqali (ribociclib) - Drug Insight and Market Forecast - 2030

By Delve Insight

Overview "Kisqali (ribociclib) - Drug Insight and Market Forecast - 2030" report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Kisqali (ri ...

20-Feb-2020 $2750

Lumizyme (alglucosidase alfa) - Drug Insight and Market Forecast - 2030

By Delve Insight

Overview "Lumizyme (alglucosidase alfa) - Drug Insight and Market Forecast - 2030" report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Lu ...

20-Feb-2020 $2750

Luxturna (voretigene neparvovec-rzyl) - Drug Insight and Market Forecast - 2030

By Delve Insight

Overview "Luxturna (voretigene neparvovec-rzyl) - Drug Insight and Market Forecast - 2030" report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture o ...

20-Feb-2020 $2750

Nexavar (sorafenib) - Drug Insight and Market Forecast - 2030

By Delve Insight

Overview "Nexavar (sorafenib) - Drug Insight and Market Forecast - 2030" report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Nexavar (sor ...

20-Feb-2020 $2750

Nplate (romiplostim) Romiplate - Drug Insight and Market Forecast - 2030

By Delve Insight

Overview "Nplate (romiplostim)Romiplate - Drug Insight and Market Forecast - 2030" report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Np ...

20-Feb-2020 $2750

Ofev (nintedanib) - Drug Insight and Market Forecast - 2030

By Delve Insight

Overview "Ofev (nintedanib) - Drug Insight and Market Forecast - 2030" report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Ofev (nintedan ...

20-Feb-2020 $2750

Prevymis (letermovir) - Drug Insight and Market Forecast - 2030

By Delve Insight

Overview "Prevymis (letermovir) - Drug Insight and Market Forecast - 2030" report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Prevymis ( ...

20-Feb-2020 $2750

Promacta/Revolade (eltrombopag) - Drug Insight and Market Forecast - 2030

By Delve Insight

Overview "Promacta/Revolade (eltrombopag) - Drug Insight and Market Forecast - 2030" report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the ...

20-Feb-2020 $2750

Rhopressa (netarsudil ophthalmic solution) - Drug Insight and Market Forecast - 2030

By Delve Insight

Overview "Rhopressa (netarsudil ophthalmic solution) - Drug Insight and Market Forecast - 2030" report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed pict ...

20-Feb-2020 $2750

Rocklatan (netarsudil and latanoprost ophthalmic solution) - Drug Insight and Market Forecast - 2030

By Delve Insight

Overview "Rocklatan (netarsudil and latanoprost ophthalmic solution) - Drug Insight and Market Forecast - 2030" report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. ...

20-Feb-2020 $2750